Clin2
NCT05450822Possibly a fitRecruiting

Personalized testing to guide treatment for epilepsy

Epilepsy

Treatments studied

Part of Brain & nervous system clinical trials.

This trial uses detailed brain tests to better match people with epilepsy to the right treatment. It may help by using “precision medicine” methods to understand what in the brain is driving seizures.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
550 people
Ages
16 years to 55 years
Study type
Observational

Who can take part

  • You’re age 16–55 (for one group) or 18–55 (for another group)
  • You either have suspected epilepsy without an official diagnosis, or you have a confirmed epilepsy diagnosis
  • You must be able to have MRI scans (no pacemakers/metal implants, and you can tolerate being in the scanner)
  • If you’re in the group that uses PET scans, you must be able to complete PET testing
  • You must be able to safely take levetiracetam or lamotrigine, and avoid interacting medicines
  • No pregnancy or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07490769Recruiting· Phase 3
Taking levetiracetam three times daily for epilepsy

This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.

Riyadh, Riyadh Region
NCT06794606Recruiting
Study for drug-resistant focal epilepsy

This trial looks at ways to diagnose and treat focal epilepsy that isn't controlled by medications. It includes patients with or without a visible brain lesion on imaging.

Milan
NCT07110337Recruiting
Diagnosing epilepsy to help guide treatment

This trial tests a new device to help diagnose epilepsy in people whose previous EEG brain monitoring did not give clear answers. If you have drug-resistant epilepsy with at least one seizure a month on average, this study may help find better treatment options.

Birmingham, Alabama
NCT07046676Recruiting· Phase 4
Using genetics to personalize valproate treatment for epilepsy

This trial studies how a person's genes affect their response to the epilepsy drug valproate. The goal is to find the best dose for each patient to improve seizure control and reduce side effects.

Hengyang, Hunan
NCT05944692Recruiting
Tripolar EEG test during seizure monitoring

This study checks whether a new type of EEG recording (a brain wave test) can detect seizure activity in people with epilepsy. You may join if you are already scheduled for routine and video EEG testing (and possibly inpatient monitoring) as part of your clinical care, including a brain MRI.

Phoenix, Arizona
NCT06212609Recruiting
Personalized brain stimulation for kids with hard-to-control epilepsy

This trial tests a personalized brain stimulation method (transcranial electrical stimulation) to reduce seizures in children with hard-to-control partial epilepsy. It aims to find the best stimulation spot and settings for each patient by using advanced brain scans.

Amiens

Hear when a new Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.